Reporting, analysis and commentary on Medicare from Speedway Scene, drawn together from across our coverage.
Foundayo, Eli Lilly's oral GLP-1 pill approved by the FDA on April 1, 2026, becomes available to eligible Medicare beneficiaries for a flat $50 monthly copay starting July 1 under a federal demonstration program running through 2027.
This archive gathers Speedway Scene coverage of Medicare, bringing together the reporting, analysis and commentary connected to the subject.
The essential morning briefing on the markets, business and world developments that shape the day ahead.
